209 related articles for article (PubMed ID: 12050022)
1. Titanium complexes in cancer treatment.
Meléndez E
Crit Rev Oncol Hematol; 2002 Jun; 42(3):309-15. PubMed ID: 12050022
[TBL] [Abstract][Full Text] [Related]
2. Titanium and vanadium complexes as anticancer agents.
Kostova I
Anticancer Agents Med Chem; 2009 Oct; 9(8):827-42. PubMed ID: 19538167
[TBL] [Abstract][Full Text] [Related]
3. Coordination Complexes of Titanium(IV) for Anticancer Therapy.
Tshuva EY; Miller M
Met Ions Life Sci; 2018 Feb; 18():. PubMed ID: 29394027
[TBL] [Abstract][Full Text] [Related]
4. Anti-tumoral Titanium
Zhao T; Wang P; Zhang X; Liu N; Zhao W; Zhang Y; Yuan P; Li S; Yang M; Yang Z; Huhn T
Curr Top Med Chem; 2023; 23(19):1835-1849. PubMed ID: 37151173
[TBL] [Abstract][Full Text] [Related]
5. Synthesis, characterization, cytotoxicity, and hydrolytic behavior of C2- and C1-symmetrical Ti(IV) complexes of tetradentate diamine bis(phenolato) ligands: a new class of antitumor agents.
Peri D; Meker S; Shavit M; Tshuva EY
Chemistry; 2009; 15(10):2403-15. PubMed ID: 19156656
[TBL] [Abstract][Full Text] [Related]
6. Different ortho and para electronic effects on hydrolysis and cytotoxicity of diamino bis(phenolato) "salan" Ti(IV) complexes.
Peri D; Meker S; Manna CM; Tshuva EY
Inorg Chem; 2011 Feb; 50(3):1030-8. PubMed ID: 21214265
[TBL] [Abstract][Full Text] [Related]
7. Antitumor titanium compounds.
Caruso F; Rossi M
Mini Rev Med Chem; 2004 Jan; 4(1):49-60. PubMed ID: 14754443
[TBL] [Abstract][Full Text] [Related]
8. Non platinum metal complexes as anti-cancer drugs.
Ott I; Gust R
Arch Pharm (Weinheim); 2007 Mar; 340(3):117-26. PubMed ID: 17315259
[TBL] [Abstract][Full Text] [Related]
9. Structure-activity studies of Ti(IV) complexes: aqueous stability and cytotoxic properties in colon cancer HT-29 cells.
Hernández R; Lamboy J; Gao LM; Matta J; Román FR; Meléndez E
J Biol Inorg Chem; 2008 Jun; 13(5):685-92. PubMed ID: 18288505
[TBL] [Abstract][Full Text] [Related]
10. Titanium(IV) targets phosphoesters on nucleotides: implications for the mechanism of action of the anticancer drug titanocene dichloride.
Guo M; Guo Z; Sadler PJ
J Biol Inorg Chem; 2001 Sep; 6(7):698-707. PubMed ID: 11681703
[TBL] [Abstract][Full Text] [Related]
11. DNA binding mode of ruthenium complexes and relationship to tumor cell toxicity.
Brabec V; Nováková O
Drug Resist Updat; 2006 Jun; 9(3):111-22. PubMed ID: 16790363
[TBL] [Abstract][Full Text] [Related]
12. Tumor inhibition by titanocene complexes: influence upon two xenografted human lung carcinomas.
Köpf-Maier P
J Cancer Res Clin Oncol; 1987; 113(4):342-8. PubMed ID: 3036884
[TBL] [Abstract][Full Text] [Related]
13. A comparative chemical-biological evaluation of titanium(IV) complexes with a salan or cyclopentadienyl ligand.
Schur J; Manna CM; Deally A; Köster RW; Tacke M; Tshuva EY; Ott I
Chem Commun (Camb); 2013 May; 49(42):4785-7. PubMed ID: 23598498
[TBL] [Abstract][Full Text] [Related]
14. Study of the cytotoxicity and particle action in human cancer cells of titanocene-functionalized materials with potential application against tumors.
García-Peñas A; Gómez-Ruiz S; Pérez-Quintanilla D; Paschke R; Sierra I; Prashar S; del Hierro I; Kaluđerović GN
J Inorg Biochem; 2012 Jan; 106(1):100-10. PubMed ID: 22112846
[TBL] [Abstract][Full Text] [Related]
15. Hydrolytic metal with a hydrophobic periphery: titanium(IV) complexes of naphthalene-2,3-diolate and interactions with serum albumin.
Tinoco AD; Eames EV; Incarvito CD; Valentine AM
Inorg Chem; 2008 Sep; 47(18):8380-90. PubMed ID: 18710217
[TBL] [Abstract][Full Text] [Related]
16. Observed hydrolysis of fluorine substituted bis(β-diketonato)-dichlorotitanium(IV) complexes.
Kuhn A; Conradie J
Dalton Trans; 2015 Mar; 44(11):5106-13. PubMed ID: 25670035
[TBL] [Abstract][Full Text] [Related]
17. Active cytotoxic reagents based on non-metallocene non-diketonato well-defined C2-symmetrical titanium complexes of tetradentate bis(phenolato) ligands.
Shavit M; Peri D; Manna CM; Alexander JS; Tshuva EY
J Am Chem Soc; 2007 Oct; 129(40):12098-9. PubMed ID: 17877357
[No Abstract] [Full Text] [Related]
18. Binding and hydrolysis studies of antitumoural titanocene dichloride and Titanocene Y with phosphate diesters.
Erxleben A; Claffey J; Tacke M
J Inorg Biochem; 2010 Apr; 104(4):390-6. PubMed ID: 20036426
[TBL] [Abstract][Full Text] [Related]
19. Unexpected influence of stereochemistry on the cytotoxicity of highly efficient Ti(IV) salan complexes: new mechanistic insights.
Manna CM; Armony G; Tshuva EY
Chemistry; 2011 Dec; 17(50):14094-103. PubMed ID: 22076809
[TBL] [Abstract][Full Text] [Related]
20. Development and future prospects of selective organometallic compounds as anticancer drug candidates exhibiting novel modes of action.
Parveen S; Arjmand F; Tabassum S
Eur J Med Chem; 2019 Aug; 175():269-286. PubMed ID: 31096151
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]